Previous Close | 13.13 |
1-Year Change | 39.98% |
6-Months Change | 20.68% |
3-Months Change | 12.22% |
Moving Avg (50d) | 11.865 |
Moving Avg (200d) | 11.592 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 15.8B |
Beta (3-Years) | 0.75 |
Revenue Growth (ttm) | -7.55% |
Net Profit Margin (ttm) | 11.86% |
Return On Assets (ttm) | 3.76% |
EPS (ttm) | 1.51 |
PE Ratio (ttm) | 8.7 |
Dividend Yield | 2.74% |
Asset Description: | Viatris Inc. |
Predicted Direction: | Buy |
Signal Strength: | Buy |
Forecast Date: | 2024-11-19 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
12.867 | 12.474 | 12.211 | 11.817 | 11.161 | 10.504 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Pharmaceuticals |
Country: | United States |
Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020. The name of the corporation comes from the Latin words via, meaning path, and tris, which means three, referring to the path to three main objectives the corporation... Wikipedia